Clinical Trial Update: Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the fixed-dose HIV regimen Bictegravir/Emtricitabine/Tenofovir Alafenamide for newborns exposed to HIV, with status currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1-infection | Phase 1 | Status: ACTIVE_NOT_RECRUITING